Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by PoorOpinionon Nov 28, 2018 1:03pm
141 Views
Post# 29034338

RE:RE:RE:RE:RE:RE:RE:RE:Citagenix

RE:RE:RE:RE:RE:RE:RE:RE:CitagenixNobody is hiding fact. Last 'facts' I brought to this board was was how backwards the analysts sales for Citigenix have gone over the past two years.

1) You started this thread worrying about the original investors returns. If you did your DD you would know It wasnt citigenix that killed their holdings it was the cancelled PhaseI trial. One guy lied about a hep virus infection and disaster! The company lost >90% of its value. It lost the $10million of investment waiting for that trial to successfully finish. It was a dead duck at that point. From that point just survival was a huge achievement and given we are now funded thru to the end of a long Phase II then you could easily say job done. Look at the value they've managed to squeeze out of a dead duck, I'm in the green from slowly accumulating from those darkest days.

2) I actually think Citigenix was more than just a growth opportunity (which so far has failed). If Phase I succeeds they would never have bought Citagenix, they would have just have pushed on with the trial drugs. Its main job has always been as leverage, more so when the market was unlikely to ever just invest in the HS tech after failed Phase I. So again given we are here now funded to the end of Phase II then that strategy succeeded no matter the failure to break into the US market or make you stinking rich.

3) People keep telling you, you bought into a small, provincial, Canadian biotech struggling to stay afloat, thats been the story since the PhaseI failure. You say did your DD, you should know that. You want it to be a highflying, MIT  and Harvard run, Californian darling of the stock market. It isnt! It never will be! You're not investing, or bring us the truth, you're dreaming! And given you're attitude your dream seems to have gone sour.

The company executed yesterday on another small hurdle on the path to their still challenging near-term goal of a US/EU deal. It didnt get eff'd up, be grateful for that, I am. That's as much pumping as I'm prepared to do.


CyrolQue wrote:

the least interesting aspect of the company has cost shareholders millions. Mgmt has either lied time and again about Citagenix or just failed to turn the lemon company they bought around. The reason they bought Citagenix is dubious at best and the result was millions lost in dilution and negative cashflow.

I’ll keep on posting the hard and verifiable facts. Not for you, but for the newcomers. They ought to know the other side of the coin that you and many other pumpers are diligently trying to hide. Maybe that will play its tiny bit of a role in motivating ATE mgmt to stop screwing its shareholders.

I don’t blame you. You’re just a sheep blindly following the flock, hoping the shepherd will lead you to the promise land instead of the slaughterhouse.



PoorOpinion wrote: I heard there's a whole bunch of superstar CEO's all queuing up, just waiting to make Cyrol and the rest of us super rich. That's what they're in the game for obviously.

On a day the management execute again on the lead product Cyrol has his eyes on the least interesting aspect of this company yet again.

Goaweigh wrote: And yet here you are with eyes wide open following this group of incompetent managers on a  daily basis.
I guess you're just hedging your bets in case these incompetent bozos get lucky and somehow miraculously discover a blockbuster drug platform and the Co. get's bought out for billions of dollars. 
So you're not a complete idiot which is good. 

But don't fret, I can, with almost absolute certainty, assure you that your dream of Legault getting sacked will happen eventually. Pfizer or Bayer or whoever won't need his services for long and he will probably be very happy to depart with his golden parachute and a large wad of cash. 
If things work out I'm thinking he could get sacked sometime next year maybe.       



CyrolQue wrote: Yep, I guess you're right. I'm not the type that blidly follows incompetent managers. This I guess is more your style. After all, likes attracts like.


Goaweigh wrote: I feel very sorry for the people who have been here for 5 years and I'm hoping they get fed up and sell me some stock at .20
As far as competition goes, golly you're right, just walk down the pain relief isle of any pharmacy and you can see just how many differant pills you can take for a hurty knee but maybe they'll find a little shelf space for us somewhere, at least that's the dream.

This is very risky, sortof like a biotech in that regard, and I don't think you are emotionally suited for this type of investment. 
Maybe try some widows and orphans stocks, things like GE, all blue sky with no downside. 
 
 

 

 

 




Bullboard Posts